| (USD) | Dec 2023 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -11.06M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HEPA returned +36.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +25.0% |
| 1 year | +36.4% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | $2,844,800.00 (Jun 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in HEPA would be worth today ›No. Hepion Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Hepion Pharmaceuticals, Inc. is part of the Healthcare sector.
Hepion Pharmaceuticals, Inc. has a market cap of 6.77M USD, based on the latest quote.
